GLP-1 receptor localization in monkey and human tissue: Novel distribution revealed with extensively validated monoclonal antibody

Endocrinology

Volumn 155, Issue 4, 2014, Pages 1280-1290

  Pyke, Charles ^a   Heller, R Scott ^a   Kirk, Rikke K ^a   Ørskov, Cathrine ^a   Reedtz Runge, Steffen ^a   Kaastrup, Peter ^a   Hvelplund, Anders ^a   Bardram, Linda ^c   Calatayud, Dan ^c   Knudsen, Lotte Bjerre ^b  

^a Department of Histology and Imaging ^*  (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 I 125; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ACINAR CELL; ANIMAL CELL; ANIMAL TISSUE; ARTERIOLE; ARTERY WALL; ARTICLE; BRUNNER GLAND; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DISTRIBUTION; DUODENUM; EPITHELIUM CELL; FEMALE; GASTROINTESTINAL TRACT; HAPLORHINI; HEART; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY; LIGAND BINDING; LIVER; LUNG; MALE; MOUSE; MUSCLE CELL; MYENTERIC PLEXUS; NONHUMAN; NORMAL HUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINUS NODE; SMOOTH MUSCLE FIBER; STOMACH; TARGET ORGAN; THYROID GLAND; VALIDATION STUDY;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD PRESSURE; BODY WEIGHT; CELL LINE; CRICETINAE; DUODENUM; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HAPLORHINI; HEART RATE; HUMANS; INSULIN; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDES; PROTEIN BINDING; RECEPTORS, GLUCAGON; TISSUE DISTRIBUTION; TRANSFECTION; VENOMS;

EID: 84897852105     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1934     Document Type: Article

References (36)

1. Brubaker PL, Drucker DJ. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels. 2002;8:179-188.
2. Thorens B. Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA. 1992;89:8641-8645.
3. Campos RV, Lee YC, Drucker DJ. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology. 1994;134:2156-2164. (Pubitemid 24142957)
4. Bullock BP, Heller RS, Habener JF. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology. 1996;137:2968-2978. (Pubitemid 26192194)
5. Dunphy JL, Taylor RG, Fuller PJ. Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression. Mol Cell Endocrinol. 1998;141:179-186. (Pubitemid 28393391)
6. Wei Y, Mojsov S. Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett. 1995;358:219-224.
7. /- mice. Endocrinology. 2013;154:127-139.
8. Körner M, Stöckli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med. 2007;48:736-743. (Pubitemid 47604973)
9. Madsen LW, Knauf JA, Gotfredsen C, et al. GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation. Endocrinology. 2012;153:1538-1547.
10. Heller RS, Kieffer TJ, Habener JF. Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing α-cells of the rat endocrine pancreas. Diabetes. 1997;46:785-791. (Pubitemid 27188255)
11. Xu G, Kaneto H, Lopez-Avalos MD, Weir GC, Bonner-Weir S. GLP-1/exendin-4 facilitates β-cell neogenesis in rat and human pancreatic ducts. Diabetes Res Clin Pract. 2006;73:107-110. (Pubitemid 43765553)
12. Tornehave D, Kristensen P, Rømer J, Knudsen LB, Heller RS. Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J Histochem Cytochem. 2008;56:841-851.
13. G12D mouse model. Diabetes. 2012;61:1250-1262.
14. Michel MC, Wieland T, Tsujimoto G. How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol. 2009;379:385-388.
15. Pradidarcheep W, Stallen J, Labruyère WT, Dabhoiwala NF, Michel MC, Lamers WH. Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol. 2009;379:397-402.
16. Pradidarcheep W, Labruyère WT, Dabhoiwala NF, Lamers WH. Lack of specificity of commercially available antisera: better specifications needed. J Histochem Cytochem. 2008;56:1099-1111.
17. 4-receptor lack specificity. Naunyn Schmiedebergs Arch Pharmacol. 2012;385:125-135.
18. Pyke C, Knudsen LB. The glucagon-like peptide-1 receptor - or not? Endocrinology. 2013;154:4-8.
19. Runge S, Schimmer S, Oschmann J, et al. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain. Biochemistry. 2007;46:5830-5840. (Pubitemid 46764131)
20. Scrocchi LA, Brown TJ, MaClusky N, et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med. 1996;2:1254-1258. (Pubitemid 26375413)
21. Bjerre Knudsen L, Madsen LW, Andersen S, et al. Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Endocrinology. 2010;151:1473-1486.
22. Knudsen LB, Hastrup S, Underwood CR, Wulff BS, Fleckner J. Functional importance of GLP-1 receptor species and expression levels in cell lines. Regul Pept. 2012;175:21-29.
23. Strobel O, Rosow DE, Rakhlin EY, et al. Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia. Gastroenterology. 2010;138:1166-1177.
24. Ruck P, Horny HP, Kaiserling E. Immunoreactivity of human tissue mast cells: nonspecific binding of primary antibodies against regulatory peptides by ionic linkage. J Histochem Cytochem. 1990;38:859-867. (Pubitemid 20177854)
25. Reubi JC, Perren A, Rehmann R, et al. Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass. Diabetologia. 2010;53:2641-2645.
26. Gore AC. Editorial: antibody validation requirements for articles published in endocrinology. Endocrinology. 2013;154:579-580.
27. Drucker DJ. Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls. Diabetes. 2013;62:3316-3323.
28. Moreno C, Mistry M, Roman RJ. Renal effects of glucagon-like peptide in rats. Eur J Pharmacol. 2002;434:163-167. (Pubitemid 34056575)
29. Crajoinas RO, Oricchio FT, Pessoa TD, et al. Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1. Am J Physiol Renal Physiol. 2011;301:F355-F363.
30. Thomson SC, Kashkouli A, Singh P. Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat. Am J Physiol Renal Physiol. 2012;304:F137-F144.
31. Mundil D, Cameron-Vendrig A, Husain M. GLP-1 receptor agonists: Aclinical perspective on cardiovascular effects. Diab Vasc Dis Res. 2012;9:95-108.
32. Skov J, Dejgaard A, Frøkiaer J, Holst JJ, Jonassen T, Rittig S, Christiansen JS. Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men. J Clin Endocrinol Metab. 2013;98:E664-E671.
33. Kim M, Platt MJ, Shibasaki T, et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nat Med. 2013;19:567-575.
34. Tang-Christensen M, Larsen PJ, Göke R, et al. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol. 1996;271:R848-856.
35. Orskov C, Poulsen SS, Møller M, Holst JJ. Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes. 1996;45:832-835. (Pubitemid 26168585)
36. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci. 1993;38:665-673. (Pubitemid 23121274)